-
Mashup Score: 3Post | LinkedIn - 1 year(s) ago
Last week in The Lancet Gastroenterology & Hepatology saw a focus on viral hepatitis.1) A Comment from the Coalition for Global Hepatitis Elimination (CGHE) gave an overview of the status of implementation of HBV birth dose (HepB-BD) vaccination in Africa, examining the impact of COVID-19 and Gavi, the Vaccine Alliance support on policy development. In 2018, Gavi’s Vaccine Investment Strategy…
Source: www.linkedin.comCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 0
Although sparse, available HIV and HCV incidence estimates offer insights into global levels of HIV and HCV transmission among PWID. Intensified efforts are needed to keep track of the HIV and HCV epidemics among PWID and to expand access to age-appropriate and gender-appropriate prevention services that serve young PWID and women who inject drugs.
Categories: Gastroenterology, Latest HeadlinesTweet-
New research - Artenie et al - Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis https://t.co/yIPtqE4ed1 #idtwitter #livertwitter #HIV #hepC #HCV #nohep #PWID @WHO https://t.co/PiQfE06HjF
-
-
Mashup Score: 0Status of HBV birth dose vaccination in Africa: the impact of COVID-19 and Gavi support on policy development - 1 year(s) ago
As a strategy to reach goals for hepatitis B virus (HBV) elimination by 2030, WHO recommends all newborn babies receive hepatitis B birth dose (HepB-BD) vaccine, preferably in the first 24 h of life.1 However, in 2021, only 17% of newborn babies in the WHO African region received a timely dose of HepB-BD vaccine. Of WHO regions, HepB-BD vaccination coverage is lowest in the African region; only…
Categories: Gastroenterology, Latest HeadlinesTweet-
New Comment - Njuguna et al - Status of HBV birth dose vaccination in #Africa: the impact of COVID-19 and Gavi support on policy development https://t.co/hbdI4XJLRF #HBV #HepB #nohep @GlobalHep @TFGH @gavi https://t.co/2nonLf5U2t
-
-
Mashup Score: 0
WHO have set ambitious targets to eliminate hepatitis C virus (HCV) as a public health threat by 2030. To meet these targets, most countries will need to increase HCV testing and treatment uptake, particularly among people who inject drugs. Concerningly, women who use drugs or have a history of drug use are not engaged in HCV care to the same extent as men.1 Enhancing HCV-related care so that…
Categories: Gastroenterology, Latest HeadlinesTweet-
New Comment - Marshall et al - Universal hepatitis C virus screening and treatment as part of prenatal care https://t.co/Jjs0vGan3F #livertwitter #idtwitter #nohep #viralhepatitis @KirbyInstitute https://t.co/2CU26YADtZ
-
-
Mashup Score: 0Launch of the UN Group of Friends to eliminate hepatitis - 1 year(s) ago
On Sept 20, 2022, at a side event to the 77th UN General Assembly in New York (NY, USA), representatives from Ministries of Health of nine countries (Egypt, Georgia, Sierra Leone, Nigeria, Tanzania, Ghana, Chile, Ukraine, and Mongolia) and six UN permanent missions (Egypt, Malaysia, Tanzania, Brazil, Chile, and Portugal) joined together to form a Group of Friends to eliminate hepatitis. They were…
Categories: Gastroenterology, Latest HeadlinesTweet-
New Correspondence - Ghaffar et al - Launch of the UN Group of Friends to eliminate hepatitis https://t.co/aBFX5LVoiZ #viralhepatitis #nohep #HCV #HBV #livertwitter #idtwitter https://t.co/PedbQbiWhe
-
-
Mashup Score: 0A national programme to scale-up decentralised hepatitis C point-of-care testing and treatment in Australia - 1 year(s) ago
WHO has set a goal to eliminate hepatitis C virus (HCV) infection by 2030, with targets to increase HCV diagnoses and treatment, and reduce new infections and liver-related deaths. Our ability to reach WHO targets is threatened by declines in HCV RNA testing and treatment globally.1 Increasing uptake of HCV testing is hampered by current diagnostic pathways requiring several visits and frequent…
Categories: Gastroenterology, Latest HeadlinesTweet-
New Comment - Grebely et al - A national programme to scale-up decentralised hepatitis C point-of-care testing and treatment in #Australia https://t.co/XOdz74O2Vj #livertwitter #idtwitter #nohep #viralhepatitis @jasongrebely @GregDore2
-
-
Mashup Score: 1
There has been notable global progress towards hepatitis elimination. In 2019, 30·4 million (10·3%) people living with hepatitis B knew their infection status, which was slightly higher than in 2015 (22·0 million; 9·0%), and 6·6 million (22·7%) of those diagnosed with hepatitis B received treatment, compared with 1·7 million (8·0%) in 2015. Mortality from hepatitis C has declined since 2019,…
Categories: Gastroenterology, Latest HeadlinesTweet-
New research - Cui et al - Global reporting of progress towards elimination of hepatitis B and hepatitis C https://t.co/iHTtdZGTMh #nohep #hbv #hcv #livertwitter #idtwitter @WHO https://t.co/gPTJaL8Y9D
-
-
Mashup Score: 0
Compared with use of laboratory-based SOC HCV viral load testing, the use of POC assays was associated with reduced time from antibody test to treatment initiation and increased treatment uptake. The effect of POC viral load testing is greatest when positioned within a simplified care model in which testing and treatment are provided at the same site, and, where possible, on the same day. POC HCV…
Categories: Gastroenterology, Latest HeadlinesTweet-
New research - Trickey et al - Impact of #HCV point-of-care RNA viral load testing compared with laboratory-based testing on uptake of RNA testing + treatment, and turnaround times: a systematic review and meta-analysis https://t.co/bJMuF3pAHK #livertwitter #idtwitter #nohep https://t.co/kzr6LYHNQQ
-
-
Mashup Score: 1Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study - 1 year(s) ago
At the beginning of 2020, there were an estimated 56·8 million viraemic HCV infections globally. Although this number represents a decrease from 2015, our forecasts suggest we are not currently on track to achieve global elimination targets by 2030. As countries recover from COVID-19, these findings can help refocus efforts aimed at HCV elimination.
Categories: Gastroenterology, Latest HeadlinesTweet-
Data from @PolarisObserv in our May issue helped track progress towards goals for #viralhepatitis elimination, providing global estimates of the change in #HCV prevalence and the cascade of care between 2015 and 2020 https://t.co/ExDW3GEoIS #nohep #endhep #livertwitter https://t.co/v8XnER89Ts
-
-
Mashup Score: 7A US plan for HCV elimination - 1 year(s) ago
On Nov 7, 2022, members of the White House Office of Science Technology Policy outlined plans for a US HCV elimination programme at a special session at AASLD’s The Liver Meeting. In a US context, the plan warrants praise for its ambition—many hurdles to successful elimination exist in the country, and progress has been slow and disjointed since the first interferon-free direct-acting antiviral…
Categories: Latest Headlines, PayerTweet-
RT @LancetGastroHep: New Editorial - A US plan for HCV elimination https://t.co/aoTzGj8laV #hcv #hepC #nohep #endhep #livertwitter #idtwi…
-
RT @Rob__Brierley: Last week in @LancetGastroHep saw a focus on viral hepatitis. A summary 👇 https://t.co/ko2sbzJWkC #nohep #HBV #hepB #H…